Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml

BackQ9001Assessment by chaplain servicesQ9002Counseling, individual, by chaplain servicesQ9003Counseling, group, by chaplain servicesQ9004Department of veterans affairs whole health partner servicesQ9950Injection, sulfur hexafluoride lipid microspheres, per mlQ9951Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per mlQ9953Injection, iron-based magnetic resonance contrast agent, per mlQ9954Oral magnetic resonance contrast agent, per 100 mlQ9955Injection, perflexane lipid microspheres, per mlQ9956Injection, octafluoropropane microspheres, per mlQ9957Injection, perflutren lipid microspheres, per mlQ9958High osmolar contrast material, up to 149 mg/ml iodine concentration, per mlQ9959High osmolar contrast material, 150-199 mg/ml iodine concentration, per mlQ9960High osmolar contrast material, 200-249 mg/ml iodine concentration, per mlQ9961High osmolar contrast material, 250-299 mg/ml iodine concentration, per mlQ9962High osmolar contrast material, 300-349 mg/ml iodine concentration, per mlQ9963High osmolar contrast material, 350-399 mg/ml iodine concentration, per mlQ9964High osmolar contrast material, 400 or greater mg/ml iodine concentration, per mlQ9965Low osmolar contrast material, 100-199 mg/ml iodine concentration, per mlQ9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per mlQ9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per mlQ9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mgQ9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesQ9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuriesQ9991Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mgQ9992Injection, buprenorphine extended-release (sublocade), greater than 100 mgQ9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mgQ9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mgQ9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mgQ9999Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg
Procedure codeCODABLE
Q9950
Injection, sulfur hexafluoride lipid microspheres, per ml
Part
HCPCS Level II
Q
Temporary Codes
Q9
Q9001–Q9999
Source

CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.